Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • CDSCO to hire 754...

    CDSCO to hire 754 Regulatory Officers especially to regulate Medical Devices in country:DTAB

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-04-27T15:00:51+05:30  |  Updated On 16 Aug 2021 4:40 PM IST

    New Delhi: With the various controversies relating to medical devices taking the limelight, the Government is looking forward to recruiting 754 officers to exclusively regulate the sale of medical devices and monitor their efficacy in India. It has been planned to constitute a medical device vertical with respect to manpower and infrastructure to be established in the Central Drugs Standard Control Organisation (CDSCO).


    Acting on the same, the Government has proposed to constitute a vertical body under CDSCO and hire officers to regulate the manufacture and sale of Medical Devices in the country.

    The proposal came during a Drugs Technical Advisory Board (DTAB) meeting held earlier this month. The DTAB proposal approved for the Government to place 754 officers. These officers will be distinct from the existing drug regulatory officers. Besides Medical Devices, these drug regulatory officers primarily monitor medicines and functions under the CDSCO.


    Out of these 754 officers, around 449 of these officers will be responsible to deal with regulatory affairs including affairs such as audit at manufacturing sites, granting approvals for imports, cancellation and approval of trade licenses among others.


    The remaining 305 are to be laboratory personnel who would check the effectiveness and safety of devices besides cross-checking the claims made by the manufacturers.


    The DTAB has also proposed that the new body should be led by an additional drugs controller who will be assisted by four joint drugs controllers — one each for invasive medical devices, non-invasive medical devices, in-vitro diagnostic medical devices and legal enforcement and training.


    "There should be 12 deputy drugs controllers, 48 assistant drugs controllers, 192 inspectors and 192 assistant inspectors for medical devices," the DTAB proposal reads.


    Besides, the proposal has further states the recruitment of 31 experts including orthopaediacians, dermatologists, surgeons, biomedical engineers, biocompatibility experts, and cardiologists on deputation or on contractual basis for advice on medical devices pertaining to their specialisation.


    Also Read: JnJ Faulty Hip Implants: 7 more patients found fit for compensation


    Moreover, the board agreed that CDSCO should be strengthened with respect to manpower and infrastructure to regulate all medical devices. It also recommended to include dentists and ophthalmologists in the category of experts to be recruited and manpower and infrastructure in all States should also be strengthened and an advisory may be issued to all the States in this regard.


    According to The Print, these regulatory officers would be recruited via a written examination conducted by the Union Public Service Commission(UPSC).

    Commenting on the proposal, a bureaucrat from the Ministry of Health and Family Welfare, which oversees the DTAB told The Print, "The idea is to do fresh recruitments and create a separate vertical altogether."

    ASR implantsbiocompatibility expertsbiomedical engineerscardiologistsCDSCOCentral Drugs Standard Control OrganisationdentistsdermatologistsDrug controllersDrugs Technical Advisory BoardDTABFaulty hip implantship implantsJnJJohnsonMedical DevicesmedicinesophthalmologistsorthopaediaciansSurgeonsUnion Public Service CommissionUPSC
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok